(Q51557344)

7 April 2018

title

Improved postprandial glycemic control with Humalog Mix75/25 after a standard test meal in patients with type 2 diabetes mellitus. (English)

1 reference

7 April 2018

0 references

Malone JK

1

1 reference

7 April 2018

Woodworth JR

2

1 reference

7 April 2018

Arora V

3

1 reference

7 April 2018

Yang H

4

1 reference

7 April 2018

Campaigne BN

5

1 reference

7 April 2018

Hallé JP

6

1 reference

7 April 2018

Yale JF

7

1 reference

7 April 2018

Grossman LD

8

1 reference

7 April 2018

publication date

1 February 2000

1 reference

7 April 2018

published in

Clinical Therapeutics

1 reference

7 April 2018

volume

22

1 reference

7 April 2018

issue

2

1 reference

7 April 2018

page(s)

222-230

1 reference

7 April 2018

The human insulin analogue insulin lispro

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988480-5

7 January 2021

Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988480-5

7 January 2021

Lispro Mix25 insulin as premeal therapy in type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988480-5

7 January 2021

Dosage accuracy of self-mixed vs premixed insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988480-5

7 January 2021

Nighttime insulin kinetics and glycemic control in type 1 diabetes patients following administration of an intermediate-acting lispro preparation.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988480-5

7 January 2021

THE TWO-PERIOD CHANGE-OVER DESIGN AN ITS USE IN CLINICAL TRIALS

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988480-5

7 January 2021

Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation. Humalog Mix25 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988480-5

7 January 2021

Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro-protamine formulations, insulin lispro mix25 and insulin lispro mix50. Mix50 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988480-5

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988480-5

7 January 2021

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988480-5

7 January 2021

10.1016/S0149-2918(00)88480-5

Identifiers

DOI

1 reference

7 April 2018

release_j25gxtvnrjghliw7dew2or6s6u

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/j25gxtvnrjghliw7dew2or6s6u

24 November 2022

mapped directly with Wikidata item

1 reference

7 April 2018